Innovative Drug Discovery and Development

Home Home Research Consortia Innovative Drug Discovery and Development

Innovative Drug Discovery and Development

Formerly the John S. Dunn Gulf Coast Consortium for Chemical Genomics (GCC CG) which was formed in 2003, the Consortium for Innovative Drug Discovery and Development (GCC IDDD) is a research consortium focused on providing support for Houston/Galveston scientists in advancing their therapeutics discoveries through development to the clinic. IDDD support includes collaborative networking and joint funding opportunities, shared core resources, and educational programs.

New! The Cancer Therapeutics Training Program (CTTP)

The Cancer Therapeutics Training Program (CTTP) is a multi-institutional post-doctoral training program designed to prepare post-doctoral trainees for future careers in academic and/or commercial cancer therapeutics research and development (R&D). The goal of the program is to recruit and train scientists equipped with the essential skills and knowledge necessary to translate basic cancer research discoveries into commercially viable cancer therapeutics. For more information, visit the CTTP Website.


Fannin Open House, November 10

Fannin Innovation Studio is actively seeking Therapeutics interns and has an Open House coming up on May 26th

Fannin primarily in-licenses promising, early-stage therapeutic and medical device technologies from leading academic investigators in the Texas Medical Center and on a national stage. Fannin develops and de-risks these technologies via preclinical work and engineering up through early clinical trials. Additionally, Fannin builds the business model and use case, resulting in strategic partnerships or acquisitions.

Our internship program provides hands-on operational experience in early-stage life science development. Fannin offers two tracks in our internship program: Therapeutics and Medical Devices. Our interns work closely with established and potential portfolio companies, experientially learning about biomedical commercialization. Interns might be tasked with assisting with due diligence, working on market analysis, assisting with product development, or researching and understanding key regulatory requirements. All interns work closely with the core Fannin team to ensure a beneficial and useful experience.

We have had many interns and Fellows complete our program, and we look forward to receiving interest from more of your members!


Questions? Contact Serena Miggins or Stephanie Vega


Thank you to everyone who helped make our Kickoff Mini-Symposium a success! For speaker and panel videos, Click Here.

Upcoming Events

Clinical Development of Gene Therapy Products for Rare Diseases

The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT) is hosting a virtual town hall to answer stakeholder questions related to the clinical […]

Find out more »

IDDD Roundtable Workshop: Life, Science, and Work Cultures Across the Different US Biotech/Pharma Hubs

This workshop will feature presenters from: Darren Boehning, Cooper Medical School of Rowan University; Rich Heyman, Heyman Biotech;  Melissa Landon, Cyclica; and Jeff Kovacs, Aktis Oncology.

Find out more »

CIDD San Antonio Drug Discovery Symposium

Keynote Speaker: Dr. John LaMattina, Senior Partner at PureTech Health and Former President of Research and Development, Pfizer "Pharna & Profits - Balancing Innovation, Medicine and Drug Prices"

Find out more »

2023 ASPET Guppy Tank Translational Science Pitch Competition

The “Guppy Tank” competition will showcase translational science pitches from four young scientists who will be coached by mentors with established experience in the biotech, pharma, and entrepreneurship realms. In […]

Find out more »
St. Louis Union Station Hotel, 1820 Market St.
St. Louis, Missouri 63103 United States
+ Google Map